Titlebook: Kidney Cancer; Principles and Pract Primo N. Lara,Eric Jonasch Book 2015Latest edition The Editor(s) (if applicable) and The Author(s), und

JAR

書目名稱Kidney Cancer影響因子(影響力)




書目名稱Kidney Cancer影響因子(影響力)學(xué)科排名




書目名稱Kidney Cancer網(wǎng)絡(luò)公開度




書目名稱Kidney Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Kidney Cancer被引頻次




書目名稱Kidney Cancer被引頻次學(xué)科排名




書目名稱Kidney Cancer年度引用




書目名稱Kidney Cancer年度引用學(xué)科排名




書目名稱Kidney Cancer讀者反饋




書目名稱Kidney Cancer讀者反饋學(xué)科排名

不斷的變動(dòng)

Pathologic Considerationson of the different types of renal cell carcinoma, the ancillary techniques used in the diagnosis and typing of renal cell carcinomas, and, finally, the grading and pathologic staging of renal cell carcinomas.

MOAN

Molecular Biology of Kidney Cancerinitial genetic event in most clear cell renal carcinomas is inactivation of the . tumor suppressor gene. Subsequent cooperating genetic events include gain of chromosome 5q, loss of chromosome 14q, and intragenic mutations affecting various chromatin modifiers, such as . and ., and genes linked to

Contracture

Biomarkers for Renal Cell Carcinomaovide opportunities for early detection, accurate diagnosis, and prediction of clinical outcomes with regard to response to therapy, potential tumor recurrence, and survival. They can also provide additional insight into the pathogenesis of disease. Biomarkers both provide a strategy for clustering

隨意

Genetic Heterogeneity of Kidney Cancercell cancer (RCC) are known to develop mixed responses to therapy suggesting the presence of tumor subclones and clonal selection. Advances in laboratory techniques – including next generation sequencing – have provided new means of understanding RCC intra tumor heterogeneity and clomal evolution. T

啞劇

The Metabolic Basis of Kidney Cancerdistinct genetic and molecular alterations, disparate histologic features, and unique clinical characteristics. Targeted therapies for metastatic disease have centered on alterations in the von Hippel–Lindau –hypoxia-inducible factor – vascular endothelial growth factor pathway. However, the discove

忙碌

Renal Cell Carcinoma: Clinical Presentation, Staging, and Prognostic Factorse of computed tomography (CT) imaging was thought to be the reason for the increased incidence as it led to incidental findings of renal masses. However, even between the years 2000 and 2009, the incidence of localized and distant disease has continued to increase. Cigarette smoking, obesity, end-st

書法

placebo-effect

Resistance